Atlas Trials

Trypanosomiasis, African

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Trypanosomiasis, African

RecordFirmDate
Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients (NCT05433350)Drugs for Neglected Diseases2022-07-09
Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects (NCT05256017)Drugs for Neglected Diseases2021-12-30
Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense (NCT03974178)Drugs for Neglected Diseases2019-09-29
Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense (NCT03087955)Drugs for Neglected Diseases2016-10-11
Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation (NCT02571062)Drugs for Neglected Diseases2015-03-01
Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158 (NCT01533961)Drugs for Neglected Diseases2012-02-01
Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Human African Trypanosomiasis) Administered With a Loading Dose and With Food (NCT01483170)Drugs for Neglected Diseases2011-09-01
Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda (NCT00489658)Epicentre2002-10-01
A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis (NCT00802594)Immtech Pharmaceuticals, Inc2001-08-01
Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis (NCT00330148)Epicentre2001-03-01
Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis (NCT00146627)Drugs for Neglected Diseases

Track Trypanosomiasis, African automatically

Every clearance here is in the API, with alerts when new ones post.